Objective: The paper studies the effect of intraocular lens centralized procurement on hospitalization expenses of cataract surgery patients. Methods: According to the first page of medical records in Ningbo City, the changes of disease cost, patient structure, average hospital stay of top 10 hospitals with cataract surgery cases before and after intraocular lens centralized procurement were compared and analyzed. Results: Patients with cataract surgery aged 60-80 years old accounts for nearly 70%. After intraocular lens centralized procurement, the hospitalization expenses decreased by 7.59%, among which the cost of materials decreased by 27.79%. Medical service fees, inspection fees, and drug costs increased by varying degrees, and the average length of stay was shortened by 0.32 days. Conclusions: The effect of intraocular lens centralized procurement on disease cost control is obvious, but the cost structure of different hospitals is significantly different. It is recommended that hospitals strengthen the control of disease cost under the background of DRG payment, incorporate intraocular lens into the national centralized purchase, and further reduce the cost of patients.
Key words
intraocular lens /
centralized procurement /
cataract surgery /
hospitalization expenses
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 詹磊磊,陶然,徐笑.我国60岁以上白内障患者实施手术的卫生经济学分析[J].中国医院,2019,23(6):39-41.
[2] 赵熠,李卫红,孙鹏,等.基于病案首页信息的人工晶体使用风险分析及对策[J].中国病案,2019,20(6):46-49.
[3] 国务院办公厅.关于印发治理高值医用耗材改革方案的通知[EB/OL].(2019-07-31)[2022-11-29].http://www.gov.cn/zhengce/content/2019-07/31/content_5417518.htm.
[4] 信昱辰,龚波.平稳推进高值医用耗材带量采购的若干思考[J].中国医疗保险,2019,12:69-72.
[5] 肖学,陈小玲,韩惠东,等.广东运用拍卖理论开展医用耗材带量采购的实践与思考[J].中国医疗保险,2019,9:58-61.
[6] 孙维阳,高雪,常峰,等.天津高值医用耗材带量采购的实践及经验[J].中国医疗保险,2022,4:28-32.
[7] 张雨燕子,梁曼,张大为.基于“带量采购”政策的人工晶体行业发展研究[J].中国市场,2022,20:88-90.
[8] 支晓慧,杨丽娟,孙波,等.精神专科药品国家集采政策实施效果评价[J].中国医疗保险,2022(12):11-16.
[9] 刘莹,马岩,蔡乐,等.国家集采和医保谈判药品协同管理实践分析——以北京市某三级医院为例[J].中国医疗保险,2022(12):17-22.
[10] 李佳根,赵磊,陈微,等.医院药品集采工作管理实践与思考——以吉林省某三甲医院为例[J].中国医疗保险,2022(11):99-101.
[11] 张海锋,杨迪,廖金文.集采药品结余留用政策实施研究及优化探讨[J].卫生软科学,2022,36(11):20-22.
[12] 李婵,锁驰,徐焦,等.药品集采效果评价指标体系和模型构建[J].中国医疗保险,2022(10):27-31.